|
STXBP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.822430E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.299700E-03 |
| Normal-vs-Stage2 |
1.225930E-02 |
| Normal-vs-Stage3 |
1.045820E-04 |
| Normal-vs-Stage4 |
8.01880000000921E-05 |
| Stage1-vs-Stage2 |
5.645800E-01 |
| Stage1-vs-Stage3 |
1.077830E-01 |
| Stage1-vs-Stage4 |
7.008300E-02 |
| Stage2-vs-Stage3 |
6.350400E-01 |
| Stage2-vs-Stage4 |
4.915000E-01 |
| Stage3-vs-Stage4 |
7.185000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.562900E-04 |
| Normal-vs-AfricanAmerican |
4.052600E-01 |
| Normal-vs-Asian |
2.617700E-04 |
| Caucasian-vs-AfricanAmerican |
1.941240E-01 |
| Caucasian-vs-Asian |
2.559000E-01 |
| AfricanAmerican-vs-Asian |
4.738000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63496999999735E-05 |
| Normal-vs-Female |
9.028900E-04 |
| Male-vs-Female |
8.414400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.838500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.190400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.698580E-03 |
| Normal-vs-Age(81-100Yrs) |
1.061990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.136000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.606800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.734000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.808600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.558800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.635400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.060770E-01 |
| Classical-VS-Follicular |
6.444400E-01 |
| Classical-VS-Other |
3.235200E-01 |
| Classical-VS-Normal |
3.936900E-03 |
| Tall-VS-Follicular |
2.505800E-01 |
| Tall-VS-Other |
8.536600E-01 |
| Tall-VS-Normal |
2.758400E-04 |
| Follicular-VS-Other |
5.525200E-01 |
| Follicular-VS-Normal |
8.304200E-03 |
| Other-VS-Normal |
2.236200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.591700E-04 |
| Normal-vs-N1 |
1.207430E-04 |
| N0-vs-N1 |
3.281400E-01 |
|
|
